Alejandro Benjamin Balazs, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibodies, Neutralizing | 27 | 2024 | 1978 | 3.050 |
Why?
|
Dependovirus | 13 | 2022 | 706 | 1.830 |
Why?
|
HIV Antibodies | 9 | 2023 | 1322 | 1.760 |
Why?
|
Immunization, Passive | 6 | 2021 | 623 | 1.450 |
Why?
|
Antibodies, Viral | 20 | 2024 | 3176 | 1.350 |
Why?
|
Genetic Vectors | 12 | 2021 | 3420 | 1.240 |
Why?
|
HIV Infections | 17 | 2023 | 16718 | 1.080 |
Why?
|
Gene Transfer Techniques | 7 | 2019 | 1224 | 1.040 |
Why?
|
Smallpox Vaccine | 1 | 2024 | 80 | 0.920 |
Why?
|
HIV-1 | 12 | 2023 | 6939 | 0.850 |
Why?
|
AIDS Vaccines | 5 | 2022 | 938 | 0.830 |
Why?
|
HIV | 3 | 2021 | 1604 | 0.810 |
Why?
|
Viral Vaccines | 2 | 2024 | 636 | 0.770 |
Why?
|
Immunity, Humoral | 3 | 2021 | 598 | 0.690 |
Why?
|
Immunoglobulin G | 8 | 2023 | 4560 | 0.690 |
Why?
|
Antibody Formation | 6 | 2024 | 1402 | 0.690 |
Why?
|
Influenza Vaccines | 3 | 2022 | 738 | 0.500 |
Why?
|
Vagina | 2 | 2022 | 825 | 0.470 |
Why?
|
Immunization | 2 | 2014 | 1256 | 0.420 |
Why?
|
Coronavirus | 2 | 2021 | 158 | 0.330 |
Why?
|
CD4-Positive T-Lymphocytes | 7 | 2022 | 4386 | 0.300 |
Why?
|
Animals | 35 | 2024 | 168757 | 0.290 |
Why?
|
Hematopoietic Stem Cells | 7 | 2023 | 3386 | 0.290 |
Why?
|
Viral Envelope Proteins | 2 | 2022 | 635 | 0.290 |
Why?
|
Influenza, Human | 2 | 2020 | 1479 | 0.280 |
Why?
|
Transgenes | 3 | 2019 | 1009 | 0.270 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 3870 | 0.240 |
Why?
|
Monkeypox virus | 1 | 2024 | 48 | 0.240 |
Why?
|
Hemangioblasts | 1 | 2023 | 28 | 0.240 |
Why?
|
Vaccines, Virus-Like Particle | 1 | 2024 | 40 | 0.230 |
Why?
|
Neutralization Tests | 3 | 2021 | 758 | 0.230 |
Why?
|
Nursing Homes | 7 | 2023 | 1036 | 0.220 |
Why?
|
Host-Pathogen Interactions | 2 | 2021 | 1477 | 0.210 |
Why?
|
Mice | 24 | 2024 | 81183 | 0.210 |
Why?
|
HEK293 Cells | 4 | 2021 | 4204 | 0.200 |
Why?
|
Primates | 1 | 2024 | 545 | 0.200 |
Why?
|
Humans | 61 | 2024 | 744343 | 0.190 |
Why?
|
Thoracic Neoplasms | 1 | 2023 | 268 | 0.190 |
Why?
|
Viral Tropism | 1 | 2021 | 101 | 0.190 |
Why?
|
Antibodies, Monoclonal | 5 | 2023 | 9274 | 0.190 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 307 | 0.180 |
Why?
|
Glycoproteins | 2 | 2022 | 2263 | 0.180 |
Why?
|
Vaccines | 2 | 2021 | 822 | 0.180 |
Why?
|
Immunotherapy | 1 | 2015 | 4445 | 0.180 |
Why?
|
Disease Models, Animal | 7 | 2022 | 18029 | 0.180 |
Why?
|
Complement Activation | 1 | 2021 | 453 | 0.170 |
Why?
|
Malaria, Falciparum | 2 | 2021 | 1077 | 0.170 |
Why?
|
Herpes Simplex | 1 | 2022 | 470 | 0.170 |
Why?
|
Vaccines, Synthetic | 4 | 2022 | 634 | 0.170 |
Why?
|
Epitopes | 4 | 2022 | 2571 | 0.170 |
Why?
|
Bone Marrow Cells | 2 | 2010 | 2513 | 0.170 |
Why?
|
Hematopoiesis | 2 | 2023 | 2072 | 0.170 |
Why?
|
Immunoglobulin M | 2 | 2020 | 1537 | 0.170 |
Why?
|
Cross Reactions | 1 | 2020 | 841 | 0.160 |
Why?
|
Macrophages, Alveolar | 1 | 2021 | 407 | 0.160 |
Why?
|
Plasmodium falciparum | 2 | 2021 | 1732 | 0.160 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 805 | 0.160 |
Why?
|
Immune Evasion | 1 | 2021 | 360 | 0.150 |
Why?
|
SAIDS Vaccines | 1 | 2018 | 166 | 0.150 |
Why?
|
Immunoglobulin A | 1 | 2020 | 992 | 0.150 |
Why?
|
Transduction, Genetic | 1 | 2019 | 913 | 0.140 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2016 | 50 | 0.140 |
Why?
|
Phagocytosis | 1 | 2021 | 1539 | 0.130 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1878 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1366 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
Mice, SCID | 3 | 2021 | 2716 | 0.130 |
Why?
|
Mutation | 4 | 2021 | 29786 | 0.120 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2016 | 271 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2022 | 4479 | 0.120 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2022 | 2026 | 0.120 |
Why?
|
CD4 Immunoadhesins | 1 | 2013 | 12 | 0.110 |
Why?
|
Lentivirus | 2 | 2020 | 501 | 0.110 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 1017 | 0.110 |
Why?
|
Malaria Vaccines | 1 | 2014 | 158 | 0.110 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.110 |
Why?
|
Dendritic Cells | 2 | 2022 | 2725 | 0.110 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 5524 | 0.110 |
Why?
|
Leukocytes, Mononuclear | 2 | 2023 | 1836 | 0.110 |
Why?
|
Mice, Inbred BALB C | 3 | 2022 | 6386 | 0.110 |
Why?
|
Muscle Cells | 1 | 2013 | 197 | 0.100 |
Why?
|
Receptors, CCR5 | 1 | 2014 | 497 | 0.100 |
Why?
|
Protein Engineering | 1 | 2015 | 540 | 0.100 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2014 | 370 | 0.100 |
Why?
|
Interleukin-6 | 1 | 2020 | 3200 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2022 | 5442 | 0.090 |
Why?
|
Alleles | 1 | 2022 | 6933 | 0.090 |
Why?
|
Vaccination | 4 | 2023 | 3278 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2018 | 7913 | 0.090 |
Why?
|
Interleukin-7 | 1 | 2010 | 142 | 0.090 |
Why?
|
Immunization, Secondary | 2 | 2022 | 340 | 0.090 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2013 | 459 | 0.080 |
Why?
|
Neoplasms | 3 | 2022 | 21683 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2021 | 4665 | 0.080 |
Why?
|
RNA, Messenger | 5 | 2023 | 13033 | 0.080 |
Why?
|
Macaca mulatta | 3 | 2021 | 2375 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3712 | 0.080 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.080 |
Why?
|
Survival Analysis | 1 | 2020 | 10252 | 0.080 |
Why?
|
Antigens, Viral | 2 | 2022 | 1035 | 0.080 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 21827 | 0.070 |
Why?
|
Communicable Diseases | 1 | 2016 | 880 | 0.070 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2016 | 2232 | 0.070 |
Why?
|
Genetic Engineering | 1 | 2013 | 951 | 0.070 |
Why?
|
Antibodies, Protozoan | 2 | 2021 | 253 | 0.070 |
Why?
|
Up-Regulation | 1 | 2016 | 4217 | 0.070 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.070 |
Why?
|
Hepatitis C, Chronic | 1 | 2014 | 1031 | 0.070 |
Why?
|
Bone Marrow Diseases | 1 | 2008 | 231 | 0.070 |
Why?
|
Cytokines | 1 | 2020 | 7322 | 0.070 |
Why?
|
Pandemics | 2 | 2023 | 8388 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2010 | 970 | 0.070 |
Why?
|
CD4 Lymphocyte Count | 1 | 2011 | 2559 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2021 | 63114 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5456 | 0.060 |
Why?
|
Female | 12 | 2023 | 380194 | 0.060 |
Why?
|
Health Personnel | 3 | 2023 | 3218 | 0.060 |
Why?
|
Genomic Instability | 1 | 2008 | 695 | 0.060 |
Why?
|
Antibodies, Blocking | 1 | 2024 | 253 | 0.060 |
Why?
|
Virus Replication | 1 | 2011 | 2534 | 0.060 |
Why?
|
Cell Line | 5 | 2021 | 15997 | 0.060 |
Why?
|
Nucleocapsid | 1 | 2023 | 59 | 0.060 |
Why?
|
Vaccines, Combined | 1 | 2023 | 69 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2005 | 1827 | 0.050 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15540 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Ohio | 1 | 2023 | 337 | 0.050 |
Why?
|
Rhode Island | 1 | 2023 | 347 | 0.050 |
Why?
|
Viral Load | 3 | 2022 | 3299 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Poly I-C | 1 | 2022 | 115 | 0.050 |
Why?
|
HIV Core Protein p24 | 1 | 2022 | 256 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2011 | 1715 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 916 | 0.050 |
Why?
|
Endothelium | 1 | 2023 | 778 | 0.050 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2023 | 401 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 40075 | 0.050 |
Why?
|
Gene Expression | 3 | 2016 | 7799 | 0.050 |
Why?
|
Containment of Biohazards | 1 | 2020 | 37 | 0.050 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2020 | 26 | 0.050 |
Why?
|
Lymphoid Tissue | 1 | 2022 | 455 | 0.050 |
Why?
|
Tropism | 1 | 2019 | 41 | 0.050 |
Why?
|
Vero Cells | 1 | 2021 | 485 | 0.040 |
Why?
|
Lactation | 1 | 2022 | 412 | 0.040 |
Why?
|
Toll-Like Receptor 7 | 1 | 2020 | 172 | 0.040 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2021 | 349 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1692 | 0.040 |
Why?
|
Graft Survival | 2 | 2010 | 3737 | 0.040 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 270 | 0.040 |
Why?
|
HIV Antigens | 1 | 2020 | 347 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 541 | 0.040 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2021 | 279 | 0.040 |
Why?
|
Antigens, Ly | 1 | 2019 | 291 | 0.040 |
Why?
|
Doxorubicin | 1 | 1985 | 2234 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13102 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9734 | 0.040 |
Why?
|
Viremia | 1 | 2021 | 736 | 0.040 |
Why?
|
Male | 7 | 2023 | 350118 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2021 | 1723 | 0.040 |
Why?
|
Toll-Like Receptor 4 | 1 | 2020 | 565 | 0.040 |
Why?
|
Plasma Cells | 1 | 2020 | 591 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2023 | 1607 | 0.040 |
Why?
|
Adult | 5 | 2023 | 214055 | 0.040 |
Why?
|
Hydrocortisone | 1 | 1985 | 1826 | 0.040 |
Why?
|
Animals, Newborn | 1 | 2022 | 2726 | 0.040 |
Why?
|
Morbidity | 1 | 2022 | 1769 | 0.040 |
Why?
|
Plasma | 1 | 2020 | 575 | 0.040 |
Why?
|
Immunocompromised Host | 1 | 2022 | 847 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 1000 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2023 | 1904 | 0.030 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2016 | 62 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2866 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1012 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1791 | 0.030 |
Why?
|
South Africa | 1 | 2021 | 1731 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2132 | 0.030 |
Why?
|
Biological Evolution | 1 | 2021 | 1076 | 0.030 |
Why?
|
Middle Aged | 4 | 2022 | 213383 | 0.030 |
Why?
|
Protozoan Proteins | 1 | 2021 | 827 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2023 | 11483 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 944 | 0.030 |
Why?
|
Sporozoites | 1 | 2014 | 82 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2460 | 0.030 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 570 | 0.030 |
Why?
|
MicroRNAs | 1 | 2010 | 3752 | 0.030 |
Why?
|
Plasmodium berghei | 1 | 2014 | 168 | 0.030 |
Why?
|
United States | 3 | 2022 | 69872 | 0.030 |
Why?
|
Simian immunodeficiency virus | 1 | 2018 | 846 | 0.030 |
Why?
|
Polysaccharides | 1 | 2020 | 1053 | 0.030 |
Why?
|
Placenta | 1 | 2022 | 1698 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10180 | 0.030 |
Why?
|
Cyclosporine | 1 | 2015 | 786 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2022 | 25625 | 0.030 |
Why?
|
Spleen | 2 | 2010 | 2362 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 693 | 0.020 |
Why?
|
Cell Proliferation | 3 | 2016 | 10481 | 0.020 |
Why?
|
DNA Primers | 1 | 2015 | 2892 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29144 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5078 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 2987 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2022 | 2958 | 0.020 |
Why?
|
Aged | 4 | 2023 | 163280 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7301 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3768 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2016 | 19229 | 0.020 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 1985 | 3523 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2010 | 793 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4751 | 0.020 |
Why?
|
Hepatocytes | 1 | 2014 | 1211 | 0.020 |
Why?
|
Cell Cycle | 1 | 2016 | 2967 | 0.020 |
Why?
|
Macrophages | 1 | 2022 | 5655 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2016 | 2503 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 53288 | 0.020 |
Why?
|
Leukemia, Myeloid | 1 | 2010 | 707 | 0.020 |
Why?
|
Hepacivirus | 1 | 2014 | 1379 | 0.020 |
Why?
|
RNA Interference | 1 | 2016 | 2889 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2504 | 0.020 |
Why?
|
Drug Resistance, Viral | 1 | 2011 | 820 | 0.020 |
Why?
|
Liver | 1 | 2022 | 7474 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1856 | 0.020 |
Why?
|
Adenine | 1 | 2011 | 936 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2938 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10943 | 0.020 |
Why?
|
Signal Transduction | 2 | 2020 | 23403 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5974 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14722 | 0.020 |
Why?
|
Sepharose | 1 | 1985 | 108 | 0.020 |
Why?
|
Tissue Extracts | 1 | 1985 | 135 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.020 |
Why?
|
Bone Marrow | 2 | 2004 | 2948 | 0.020 |
Why?
|
Genetic Variation | 1 | 2019 | 6544 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2004 | 255 | 0.010 |
Why?
|
Myeloproliferative Disorders | 1 | 2010 | 606 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1434 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9856 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13815 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2016 | 2957 | 0.010 |
Why?
|
Gamma Rays | 1 | 2004 | 320 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.010 |
Why?
|
Aging | 1 | 2022 | 8664 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2019 | 7880 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4149 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 18111 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19905 | 0.010 |
Why?
|
Microtubules | 1 | 2008 | 1090 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2010 | 12072 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4286 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3251 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10638 | 0.010 |
Why?
|
Drug Synergism | 1 | 1985 | 1792 | 0.010 |
Why?
|
Neurons | 1 | 2019 | 9338 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12951 | 0.010 |
Why?
|
Homeostasis | 1 | 2010 | 3340 | 0.010 |
Why?
|
Cattle | 1 | 1985 | 3922 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40561 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 3505 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4554 | 0.010 |
Why?
|
Cell Division | 1 | 1985 | 4568 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2765 | 0.010 |
Why?
|
Protein Binding | 1 | 2008 | 9386 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 9583 | 0.010 |
Why?
|
Child | 1 | 2022 | 77709 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 56430 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3798 | 0.010 |
Why?
|
Brain | 1 | 2019 | 26385 | 0.010 |
Why?
|
Proteins | 1 | 2008 | 6103 | 0.010 |
Why?
|
Neutrophils | 1 | 2004 | 3719 | 0.010 |
Why?
|